Funding for this research was provided by:
systematic identification of hematopoietic stem cell expansion factors (R01 HL133560-01)
rip1/rip3-calpain-stat3 and nf-kappa b pathways in aml pathogenesis and treatment (R01 CA223194-01)
Article History
Received: 21 July 2021
Revised: 4 September 2021
Accepted: 20 September 2021
First Online: 15 October 2021
Declarations
:
: The authors declare that they have no competing financial or professional interests.
: This is not applicable for this review.
: This is not applicable for this review.
: This is not applicable for this review.